Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Varenicline Nasal Spray 0.03mg Dry Eye Treatment on Ocular Surface Health, Tear Film Stability, and Ocular Discomfort

NCT07606625 is registered in ClinicalTrials.gov with University of California, Berkeley as lead sponsor.

NCT NCT07606625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Varenicline Nasal Spray 0.03mg Dry Eye Treatment on Ocular Surface Health, Tear Film Stability, and Ocular Discomfort
Lead sponsor
University of California, Berkeley
Phase
Phase 4
Overall status
Recruiting
Start date
March 6, 2026
Completion date
December 31, 2026
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, meibomian gland dysfunction